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Abstract Healing of early-gestation fetal wounds results
in scarless healing. Since the capacity for regeneration is
probably inherent to the fetal skin itself, knowledge of the
fetal skin composition may contribute to the understanding
of fetal wound healing. The aim of this study was to ana-
lyze the expression proWles of diVerent epidermal and der-
mal components in the human fetal and adult skin. In the
human fetal skin (ranging from 13 to 22 weeks’ gestation)
and adult skin biopsies, the expression patterns of several
epidermal proteins (K10, K14, K16, K17, SKALP, involu-
crin), basement membrane proteins, Ki-67, blood vessels
and extracellular matrix proteins (Wbronectin, chondroitin
sulfate, elastin) were determined using immunohistochem-
istry. The expression proWles of K17, involucrin, dermal
Ki-67, Wbronectin and chondroitin sulfate were higher in
the fetal skin than in adult skin. In the fetal skin, elastin was
not present in the dermis, but it was found in the adult skin.
The expression patterns of basement membrane proteins,
blood vessels, K10, K14, K16 and epidermal Ki-67 were
similar in human fetal skin and adult skin. In this system-
atic overview, most of the diVerences between fetal and
adult skin were found at the level of dermal extracellular
matrix molecules expression. This study suggests that,
especially, dermal components are important in fetal scar-
less healing.
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Introduction
Many studies have shown that fetal and adult wounds heal
via diVerent mechanisms [4, 18, 45]. Early- to mid-gesta-
tion fetal healing is characterized by rapid re-epithelializa-
tion, lack of inXammation and restoration of normal tissue
architecture. In contrast, adult and late-gestational skin heal
less rapidly and with the formation of a scar [18]. Under-
standing fetal scarless healing may lead to new therapeutic
strategies for improving adult wound healing. Previous
studies showed that scarless fetal healing does not require
systemic factors, such as fetal serum or amniotic Xuid
[28, 29]. Thus, the capacity for scarless repair is probably
inherent to the fetal skin itself. Knowledge of the fetal skin
composition and architecture may contribute to the compre-
hension of fetal healing biology.
Several studies have been performed in which the com-
position of fetal epidermis was investigated [6, 31, 42, 44].
During fetal skin development, the epidermis changes from
a single layer of ectodermal cells at 7–8 days of gestation
into a stratiWed, keratinized epithelium at 22–24 weeks [5].
Meanwhile, the epithelial cells express diVerent patterns of
cytokeratins and proteins of the corniWed cell envelope. The
basal cell keratins, K5 and K14, are present from 8 weeks
of gestation, when the fetal epidermis consists of a basal
layer and periderm [6]. The diVerentiation-speciWc keratins
(K1 and K10) are induced between 9 and 10 weeks, when a
third layer of cells (stratum intermedium) forms between
the basal and periderm layers. Other keratins, such as K8
and K19, are present during fetal skin development, but are
absent in the adult epidermis [13]. Proteins involved in the
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loricrin and Wlaggrin, are detected from the time the stratum
intermedium is formed [27]. However, there are some dis-
crepancies in literature with regard to the exact expression
time and localization of these proteins [6, 27, 31].
Many investigators have analyzed the composition of
the fetal dermis [18, 45]. It was shown that the extracellu-
lar matrix (ECM) of fetal skin diVers from the ECM of
adult skin. Collagen type I is the principal component of
the ECM in both fetal and adult skin. However, the fetal
skin contains a higher ratio of collagen type III to collagen
type I than adult skin [26, 37]. Another major diVerence in
ECM content between fetal and adult skin is a higher level
of glycosaminoglycans (GAGs) in the fetal skin. The
amount of both hyaluronic acid and chondroitin sulfate is
higher in the fetal skin than in the adult skin [35, 44]. It
was suggested that GAGs play a role in fetal scarless
wound healing [34].
Besides collagen and GAGs, elastin is an important
component of the ECM. This protein is responsible for con-
nective tissue resilience and is present in the adult dermis
(i.e., 2–4%). It has been shown that (tropo)elastin is pro-
duced during fetal development; however, reports disagree
on the exact time of (tropo)elastin deposition [11, 40].
Although the composition of the fetal skin has been
investigated in many studies, the evaluation of the compo-
nents of the fetal skin has not been completed. First, con-
Xicting results have been presented in diVerent studies with
respect to the location and timing of the expression of vari-
ous proteins. Further research is necessary to clarify this
inconsistency. Second, many studies use animal models to
investigate the constituents of the fetal skin. Since the
expression of several developmental genes in humans
diVers from that in animals [14], it is reasonable to suggest
that several protein proWles in the human fetal skin deviate
from that in animal fetal skin. Third, a few fetal skin com-
ponents have not been thoroughly investigated yet. The aim
of this study was to characterize the human fetal and adult
skin, in order to give a more complete overview of the




This study was approved by the Medical Ethical Committee
of Noord-Holland, Alkmaar, The Netherlands. Human fetal
skin was harvested from the limbs of 21 aborted fetuses.
Human fetal samples were obtained from fully informed,
consenting patients undergoing elective terminations of
pregnancy. The gestational ages were estimated by
menstrual age and ranged from 13 to 22 weeks. The
embryo gestational ages and numbers were as follows: ges-
tational age 13 weeks (1), 14 weeks (1), 16 weeks (1),
17 weeks (2), 18 weeks (2), 19 weeks (4), 20 weeks (4),
21 weeks (3), 22 weeks (3). Human normal skin was
obtained from three healthy donors undergoing abdomino-
plasty after consent, according to institutional guidelines.
The age of the patients ranged from to 34 to 45 years. All
the skin samples were Wxed in either 4% formaldehyde or
kryoWx (50% ethanol, 3% PEG300) for hematoxylin and
eosin staining (H&E) and immunohistochemistry.
Primary antibodies
The tissue specimens were stained with antibodies directed
against keratin 10 (K10), keratin 14 (K14), keratin 17
(K17), keratin 16 (K16), involucrin (INV), skin-derived
antileukoproteinase (SKALP), collagen type IV (CIV),
laminin, Ki-67, CD31, -smooth muscle actine (-SMA),
elastin, Wbronectin (FN) and chondroitin sulfate (CS). See
Table 1 for antibody speciWcations.
Immunohistochemistry and immunoXuorescence
After Wxation, skin biopsies were processed for paraYn
embedding. Sections (5 m) were deparaYnized and rehy-
drated for hematoxylin and eosin staining or immunohisto-
chemical analysis. Slides were incubated with primary
antibodies, followed by incubation with secondary biotinyl-
ated rabbit anti-mouse or goat anti-rabbit polyclonal
antibody (DAKO, Glostrup, Denmark) for 1 h at room
temperature. Subsequently, the sections were stained with
streptavidin–biotin–peroxidase complex system (DAKO)
according to the manufacturer’s instructions. Peroxidase
activity was detected with DAB substrate. All sections were
counterstained with hematoxylin.
For immunoXuorescence, sections were incubated with
streptavidin–alkaline phosphatase (DAKO) after incubation
of secondary antibody. Staining was visualized using
Liquid Permanent Red (DAKO) according to the manufac-
turer’s instructions. Fluorescence was detected by
Xuorescence microscopy using a Texas Red Wlter set (exci-
tation wavelength 510–560 nm and emission wavelength
590 nm). 4,6-Diamidine-2-phenylindole (DAPI; Roche
Diagnostics, Almere, The Netherlands) was used as a
nuclear counterstain. Negative controls were performed in
the absence of the primary antibody.
Scoring of immunoreactivity
All sections were evaluated for the presence and intensity
of speciWc staining at the light-microscopic level (magniW-
cation 200£) at Wve randomly chosen regions. Staining was123
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(+) and strongly positive (++).
Proliferation in the fetal and adult skin
In each section, DAPI-positive and Ki-67-positive cells
were counted at the light-microscopic level (magniWcation
200£) in the basal layer and in the interfollicular dermis at
three randomly chosen regions. The number of positive
cells per mm2 was calculated using NIS Elements (Nikon
Instruments Europe B.V., Amstelveen, The Netherlands).
The proliferation index (PI) in the epidermis is deWned as
the number of Ki-67-positive basal cells divided by the
total number of basal cells £ 100%.
Statistical analysis
Because normal distribution of the data could not be
assumed, statistical signiWcance was determined by Mann–




In early gestation (13–14 weeks), fetal epidermis contained
a basal layer, one or two intermediate layers and a peri-
derm. At 14 weeks, the fetal dermis consisted of a Wnely
Wbrillar dermis that contained many cells (Fig. 1). From
16 weeks of gestation, hair pegs were visible that projected
into the dermis. The dermis was organized into two
regions: an upper Wbrillar papillary region and a deep retic-
ular region that contained larger Wbers. During further
development, the number of epidermal cell layers increased
and the hair pegs matured into hair follicles. Developing
eccrine sweat glands were detected from week 21.
Proliferation in the fetal epidermis and dermis
To investigate proliferation during fetal skin development,
the skin samples were stained with Ki-67 antibodies.
Ki-67-positive cells were mainly located in the basal layer
Table 1 Antibodies used in immunohistochemical analysis
Primary antibody Clone Dilution Fixation Source
Keratin 10 DE-K10 1:150 Formaldehyde Dako, Glostrup, Denmark
Keratin 14 LL002 1:50 Formaldehyde Novocastra, Newcastle Upon Tyne, UK
Keratin 17 E3 1:100 KryoWx Dako
Keratin 16 LL025 1:30 Formaldehyde Novocastra
Involucrin SY5 1:1,000 Formaldehyde Novocastra
SKALP TRAB2O 1:1,600 Formaldehyde Hycult Biotechnology, Uden, The Netherlands
Collagen type IV CIV 22 1:250 Formaldehyde Dako
Laminin Polyclonal 1:50 Formaldehyde MP Biomedicals, Illkirch, France
Ki-67 MIB-1 1:50 Formaldehyde Dako
CD31 JC70A 1:50 KryoWx Dako
(Tropo)elastin BA-4 1:500 Formaldehyde Sigma, St Louis, USA
FN Polyclonal 1:1,200 Formaldehyde Sigma
CS CS-56 1:500 Formaldehyde Sigma
-SMA 1A4 1:250 Formaldehyde Dako
Fig. 1 Histology of 14 and 20 weeks’ gestation fetal skin and of adult
skin. At 14 weeks, the epidermis consisted of a basal layer, an interme-
diate cell layer and periderm. At 20 weeks, the number of intermediate
cells layers was increased and developing hair follicles were visible.
The adult skin contained basal, spinous, granular and corniWed layers.
Scale bars 100 m123
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skin. To determine the proliferation in the epidermis during
development, the percentage of Ki-67-positive cells in the
basal layer was calculated [i.e., proliferation index (PI)].
Figure 2a shows that the median PI of early-gestational epi-
dermis (13–14 weeks) was higher than the PI of mid-gesta-
tional and adult epidermis, but this diVerence was not
signiWcant due to the low number of samples obtained in
the group of 13–14 weeks (P > 0.05, Mann–Whitney U).
The median PI of mid-gestational epidermis (16–22 weeks)
was nearly similar to the PI of adult skin.
Figure 2b illustrates the total number of cells per mm2 in
fetal and adult dermis. During fetal development, the total
number of cell per mm2 was higher in the fetal dermis than
in the adult dermis. The diVerence between fetal and adult
dermis was signiWcant at 16–22 weeks’ gestation (P < 0.05,
Mann–Whitney U). Figure 2c demonstrates that the number
of Ki-67-positive cells per mm2 was also higher in the fetal
dermis than in adult dermis. Similar to the total number of
cells, this result was signiWcant between 16 and 22 weeks
of gestation and adult skin (P < 0.05, Mann–Whitney U).
Characterization of the fetal epidermis during development
To study epidermal diVerentiation during gestation, the
presence of K10 and INV was determined. At 13–14
weeks, K10 was expressed in the intermediate layers and in
some parts of the periderm (Table 2). From week 16, K10
was only present in the intermediate layers of the fetal epi-
dermis and in the suprabasal layers of the infundibulum of
the developing hair follicles. In the adult skin, K10 was
visible in the suprabasal layers. INV was present in the
intermediate layers and periderm from week 13, and it was
found in the granular layer of the adult skin (Fig. 3;
Table 2). In the developing hair follicles, INV was detected
in the upper layers of the infundibulum, in the inner root
sheet (IRS) and in the lower part of the outer root sheet
(ORS).
To investigate stratiWcation of the fetal epidermis, the
sections were stained with antibodies directed against K14.
Similar to the adult skin, K14 was observed in the basal
layer of the fetal epidermis from 13 weeks of gestation
(Table 2). From 19 weeks, K14 was detected in the basal
Fig. 2 Proliferation during fetal skin development and in adult skin.
a Proliferation index in the fetal and adult epidermis. The proliferation
index (PI) was deWned as the number of Ki-67-positive basal cells
divided by the total number of basal cells £ 100%. Each dot represents
the mean PI of three randomly chosen regions in each section. b The
total number of cells and c Ki-67-positive cells per mm2 in the dermis
of fetal and adult skin. Each dot represents the mean total number of
cells per mm2 or the mean number of Ki-67-positive cells per mm2 of
three randomly chosen regions in each section. The broken lines
indicate the median observation in each group, except for the group of
13–14 weeks in which the mean observation of two skin samples is
indicated. Statistical signiWcance was determined by Mann–Whitney
U. *P < 0.05123
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follicles and in the sebaceous glands.
To examine the expression of proteins related to abnor-
mal diVerentiation and hyperproliferation, the presence of
K16, K17 and SKALP was studied in the fetal and adult
skin. K16 was absent in the fetal and adult epidermis
(Table 2). From week 21, K16 was only found in the hair
canal that traversed the epidermis. At 13–14 weeks, K17
was expressed in the basal layer, in the lower intermediate
cell layer and in the periderm (Fig. 3; Table 2). K17 was
present in the basal layer and lower intermediate cell layers
near developing hair follicles at week 16, but this expres-
sion gradually reduced during further development. In
developing hair follicles, K17 was visible in all layers of
the infundibulum, ORS and sebaceous glands. K17 was not
detected in adult epidermis. SKALP was absent in the adult
skin and fetal skin until 20 weeks of gestation. From week
21, SKALP was present in the upper intermediate cell lay-
ers and in the hair canal that traversed the epidermis
(Table 2).
Appearance of basement membrane proteins
To assess the presence of basement membrane during
development, the sections were stained with antibodies
directed against collagen type IV and laminin. A summary
of collagen type IV and laminin expression in the fetal and
adult skin is presented in Table 3. From week 13, both col-
lagen type IV and laminin were detected along the base-
ment membrane zone (BMZ) of the dermal–epidermal
junction (DEJ) and the dermal vasculature. Staining of the
basement membrane proteins was more abundant around
blood vessels than in the DEJ. From the appearance of
developing hair follicles (week 16), collagen type IV and
laminin were visible underneath the follicular epidermis.
Presence of blood vessels in the fetal skin
The expression of CD31 and -SMA was studied, to exam-
ine the presence of blood vessels during fetal skin develop-
ment. Table 4 summarizes the expression of these proteins
Table 2 Immunohistochemical staining of cytokeratins, involucrin (INV) and SKALP in fetal and adult epidermis
Basal Basal layer, Int intermediate layers, Perid periderm, Fol developing hair follicles
First trimester Second trimester Adult skin
13–14 weeks 16–18 weeks 19–20 weeks 21–22 wk
Basal Int Perid Basal Int Perid Fol Basal Int Perid Fol Basal Int Perid Fol Basal Spinous Granular
K10 ¡ ++ § ¡ ++ ¡ § ¡ ++ ¡ § ¡ ++ ¡ § ¡ ++ ++
K14 ++ ¡ ¡ ++ ¡ ¡ § ++ ¡ ¡ + ++ ¡ ¡ + ++ ¡ ¡
K16 ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ § ¡ ¡ ¡
K17 ++ § ++ + § ++ + § § ++ + ¡ § ++ + ¡ ¡ ¡
INV ¡ + ++ ¡ ++ ++ § ¡ ++ ++ + ¡ ++ ++ + ¡ ¡ ++
SKALP ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ § ¡ § ¡ ¡ ¡
Fig. 3 Presence of keratin 17 
(a–c) and involucrin (d–f) in 14 
and 19 weeks’ gestation fetal 
skin and of adult skin. At 
14 weeks, K17 was detected in 
the basal layer, some cells of the 
intermediate layer and in the 
periderm (a). At 19 weeks, K17 
was visible in some cells of the 
basal and intermediate layers, in 
the periderm and in developing 
hair follicles (b). Adult skin was 
negative for K17 (c). In the fetal 
skin, involucrin was observed in 
the suprabasal layers (d, e). 
Involucrin was present in the 
granular layers of adult epider-
mis (f). Scale bars 100 m123
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were visible in the fetal skin. Small blood vessels were
observed in the upper papillary region, whereas larger ones
were found in the deep reticular dermis (Fig. 4).
Characterization of the fetal dermal component
To investigate several proteins of the ECM during fetal skin
development, we stained the skin sections with antibodies
against CS, FN and elastin. Table 5 summarizes the expres-
sion of these proteins in the fetal and adult skin. From
16 weeks of gestation, CS was detected in the papillary der-
mis and in the upper part of the reticular dermis (Fig. 5). In
the adult skin, CS was only visible in the BMZ of the DEJ
and blood vessels. From 13 weeks of gestational age, FN
was observed in all the layers of the dermis in the fetal skin
(Fig. 5). In contrast, FN was only located in the BMZ of the
DEJ and vasculature in the adult skin. Elastin was not pres-
ent in the fetal skin up to week 22, but it was found in the
papillary and reticular dermis of the adult skin (Fig. 5).
Discussion
Early-gestation fetal skin has the unique ability to heal
wounds without the formation of a scar. Since the composi-
tion and architecture of ECM plays a signiWcant role in cell
function, the constitution of fetal skin may be important in
scarless healing. Therefore, knowledge of the components
and expression proWles of the fetal skin may contribute to
the understanding of fetal wound healing biology. To give
an overview of the diVerences between adult and fetal skin
composition, we have systematically assessed the protein
expression proWles of diVerent epidermal and dermal com-
ponents in the adult skin and during fetal development
between 13 and 22 weeks’ gestation. In order to clarify
conXicting results found in previous studies, all analyses
were performed in one, human-derived set of samples. This
investigation shows that the expression patterns of several
Table 3 Presence of collagen 
type IV (CIV) and laminin 
(Lam) during fetal skin develop-
ment and in adult skin
First trimester Second trimester Adult skin
13–14 weeks 16–18 weeks 19–20 weeks 21–22 weeks
DEJ Bl ves DEJ Fol Bl ves DEJ Fol Bl ves DEJ Fol Bl ves DEJ Bl ves
CIV + ++ + § ++ + + ++ + + ++ + ++
Lam + ++ + § ++ + + ++ + + ++ + ++
DEJ Dermo-epidermal junction, 
Fol developing hair follicles, 
Bl ves blood vessels
Fig. 4 Presence of blood vessels in 16 week’s gestation fetal skin (a),
in 18 weeks’ gestation skin (c) and in adult skin (b, d). In fetal and
adult dermis, CD31 (a, b) and -smooth muscle actin (c, d) were
detected in small blood vessels in the upper part of the dermis and in
larger blood vessels in the lower part of the dermis. Scale bars 100 m
Table 4 Presence of CD31 and 
-smooth muscle actin during 
fetal development and in adult 
skin
First trimester Second trimester Adult skin
13–14 weeks 16–18 weeks 19–20 weeks 21–22 weeks
Dermis Pap Ret Pap Ret Pap Ret Pap Ret
CD31 ++ + ++ + ++ + ++ ++ ++
-SMA ++ + ++ + ++ + ++ ++ ++Pap Papillary dermis, Ret reticular dermis123
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proteins (K17 and involucrin) are diVerent in the human
fetal skin than in adult skin. In contrast, the expression pro-
Wles of basement membrane proteins, blood vessels, several
cytokeratins (K10, K14, and K16), and of epidermal Ki-67
are similar in the human fetal skin and adult skin. It would
be of interest to study fetal tissue before 13 weeks and from
22 weeks, but this tissue was not available.
In the literature, there is still some discrepancy regarding
the localization and expression time of several proteins in
the human fetal skin (e.g., involucrin and elastin) and some
proteins have only been investigated in the animal fetal skin
(e.g., K16 and K17). Therefore, we studied the presence of
involucrin, elastin, K16, and K17 in our human-derived set
of fetal skin samples. Similar to Lee et al. [27] and Akiyama
et al. [2], we found involucrin expression in both intermediate
cells and periderm during fetal development. In contrast,
Lourenço et al. [30] only found presence of involucrin in
the periderm of fetal skin. Lourenço et al. collected the fetal
skin specimens from several regions of the body. Since
some parts of the fetal skin (i.e., foot and head) shows more
precocious development than other parts [23], diVerences in
biopsy location may explain this inconsistency. Similar to
two previous investigations, elastin was not detected in the
fetal skin up to 22 weeks’ gestation in the present study
[9, 38]. However, Egging et al. [11] already showed pres-
ence of tropoelastin in fetal mouse skin at embryonic day
10, which equates to approximately 4 weeks’ human gesta-
tion. Since the study of Egging et al. was performed in
mice, human-mouse diVerences may explain this dissimi-
larity. Both K17 and K16 have only been studied in mice
models [3, 36] Comparable to McGowan et al. [36], K17
was detected in the periderm, developing hair follicles and
the proximal epithelial tissues in the present study. How-
ever, McGowen et al. showed a peak expression of K17 in
the basal layer during late epidermal development. K16
expression in our study diVers from that of Bernot et al. [3].
In our investigation, we did not Wnd K16 in the fetal epider-
mis, but Bernot et al. reported the presence of K16 within
early hair germs of the mouse and in a subset of cells at the
interface of the basal and suprabasal cells. This study shows
that many diVerences exist between human and mice fetal
development.
The expression proWles of other fetal proteins are unam-
biguous in literature. In this study, the expression pattern of
those proteins were comparable to previous reports. Similar
to literature, we showed that K14 is present in the basal
layer and K10 is visible in the suprabasal layers [6, 17, 31].
In addition, the Wnding that blood vessels and basement
membrane proteins were found in the fetal skin from early
gestation is consistent with previous studies [7, 12, 20, 21,
24]. Furthermore, the observation that FN and CS were
abundantly present during fetal development resembles
other investigations [12, 16, 21, 42, 44]. However, we
found CS staining only in the upper half of the fetal dermis,
Fig. 5 Presence of chondroitin sulfate (a, b), elastin (c, d) and Wbro-
nectin (e, f) in 18 weeks’ gestation fetal skin and in adult skin. In the
fetal skin, CS was present in the upper part of the dermis (a). In the
adult skin, CS was only visible around the basement membrane zone
(b). Elastin was not present in early-gestation fetal skin (c), but it was
observed in the adult skin (d). FN was detected in the entire fetal skin
(e), but it was only present in the basement membrane zone in the adult
skin (f). Scale bars 100 m
Table 5 Presence of chondroitin sulfate (CS), Wbronectin (FN) and elastin during fetal development and in adult skin
BMZ Basement membrane zone, Pap papillary dermis, Ret reticular dermis
First trimester Second trimester Adult skin
13–14 weeks 16–18 weeks 19–20 weeks 21–22 weeks
Dermis BMZ Pap Ret BMZ Pap Ret BMZ Pap Ret BMZ Pap Ret BMZ
CS + + + § ++ ++ + ++ ++ + ++ ¡ ¡ ++
FN ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ¡ ¡ +
Elastin ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ + + ¡123
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most studies. DiVerent anti-CS monoclonal antibodies pro-
duce diVerent staining proWles [42]; therefore, this might
explain the dissimilar staining pattern observed in this
study.
In the present study, most diVerences between fetal and
adult skin were found in the expression pattern of ECM
molecules. Both FN and CS were more abundantly present
in the fetal dermis than in adult dermis, and elastin was not
found in the fetal skin up to 22 weeks of gestation. It has
long been recognized that ECM aVects cell behavior and
phenotype. Many studies show that ECM provides signal-
ing cues that regulate Wbroblast functions, including migra-
tion, diVerentiation and proliferation, during wound healing
and homeostasis [10, 15, 32]. In addition, ECM is impor-
tant in the formation of the epithelial appendages and inXu-
ences terminal diVerentiation of keratinocytes [1, 25, 41].
Therefore, it is reasonable that ECM molecules play an
important role in fetal scarless healing.
The results of this study suggest that the presence or
absence of certain ECM molecules might be beneWcial in
wound healing. Hence, a possible therapeutic intervention
for adult wound healing is the use of a dermal substitute
that contains certain ECM molecules, such as CS and FN.
Several studies have indeed shown that the use of a CS-
coated substitute improved wound healing [19, 43]. How-
ever, several reports showed that the use of elastin–collagen
matrices also promoted wound healing [8, 39]. Since in
these matrices, fragmented elastin (elastin hydrolysate) was
present rather than intact elastin Wbers, further research is
necessary to investigate the inXuence of elastin on adult
healing more thoroughly.
In addition to ECM molecules, the expression of K17
and involucrin was higher in the fetal skin than in adult
skin. It has been suggested that cells that stain positive for
K17 in the developing epidermis have a nonepidermal tis-
sue fate, such as hair follicle, gland or periderm [36]. In the
present study, K17 was especially observed in the develop-
ing appendages and in the surrounding epidermal tissue.
During further development, the expression of K17 gradu-
ally reduced in the fetal epidermis, but remained present in
the developing appendages. These Wndings support the idea
that K17-postitive cells have a nonepidermal destination. In
contrast to adult skin, involucrin was detected in all supra-
basal layers of the fetal skin. This is similar to wound heal-
ing and psoriatic skin and suggests that homeostasis is not
yet established in fetal epidermis [22, 33].
By comparing the composition of fetal and adult skin,
the present study can contribute to the identiWcation of pro-
teins that are important in scarless healing. However, this
investigation was only performed in unwounded skin sam-
ples. Many additional factors, such as cytokines and inXam-
matory cells, are important during wound healing.
Therefore, a simple description of the unwounded skin
component is not suYcient to disclose the mechanisms
involved in fetal healing. Obviously, more research is nec-
essary to unravel the mechanisms of fetal scarless healing,
but this study provides important potential clues.
In the present study, a systematic overview is given of
the diVerences between the human fetal and adult skin com-
position. In one set of human fetal and adult skin biopsies,
the expression proWles of several epidermal and dermal
proteins were determined. Hence, conXicting results found
in previous studies could be clariWed. Most diVerences
between fetal and adult skin were found in the expression
pattern of ECM molecules. This study suggests that, espe-
cially, dermal components are important in fetal scarless
healing.
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